During the official tirzepatide shortage, the FDA allowed compounding pharmacies to make copies under regulatory discretion
Font, B., Eichenberger, D., Rosenberg, L
In obesity trials, semaglutide produces roughly 16% body-weight reduction, while tirzepatide reaches close to 18% translating into average losses approaching 20 kilograms in some studies
Rather than a sudden change, most describe the experience as a steady recalibration
A study of more than 400,000 posts in the social media platform Reddit has identified previously unreported side effects from the increasingly popular GLP-1 weight loss and diabetes drugs
We review your weight-loss history, current struggles, and lab results to create a treatment plan that fits your goals and your budget